Effect of back passage of Venezuelan equine encephalomyelitis TC-83 vaccine virus on clinical, virologic, and immune responses in horses.
D000818:Animals; D001769:Blood / Q000382:microbiology; D001831:Body Temperature; D001921:Brain / Q000382:microbiology; D002478:Cells, Cultured; D004666:Encephalitis Virus, Venezuelan Equine / Q000254:growth & development / Q000276:immunology* / Q000302:isolation & purification / Q000472:pathogenicity; D004683:Encephalomyelitis, Equine / Q000209:etiology / Q000276:immunology / Q000382:microbiology / Q000662:veterinary*; D006168:Guinea Pigs; D000882:Haplorhini; D006385:Hemagglutination Inhibition Tests; D006734:Horse Diseases / Q000209:etiology / Q000276:immunology / Q000382:microbiology; D006736:Horses; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007668:Kidney; D051379:Mice; D009500:Neutralization Tests; D012007:Rectum; D018805:Sepsis / Q000662:veterinary; D014611:Vaccination / Q000662:veterinary; D014613:Vaccines, Attenuated; D010948:Viral Plaque Assay; D014765:Viral Vaccines / Q000008:administration & dosage; D014774:Virulence
D014613:Vaccines, Attenuated; D014765:Viral Vaccines